Skip to main content About News Giving All Departments Contact Us Site Map My UTSouthwestern
 University of Texas Southwestern Medical School
 
Search       
Print Friendly  
spacer Home Education Research Patient Care Faculty & Administration Resource Careers
For Patients & Public For Health Care Professionals Clinics and Hospitals
| Home > Patient Care > For Health Care Professionals > Centers & Departments >
Alzheimer's Disease Center
 ←Neurology Home 
  
 Director's Welcome 
 About Us 
 Patient Resources 
 Research 
 News 
 Events 
 Affiliations 
 

Patients

Research

About

Roger Rosenberg, M.D.

Roger Rosenberg, M.D.

Welcome to the Alzheimer's Disease Center

The Alzheimer's Disease Center at UT Southwestern is dedicated to finding ways to treat and prevent this devastating illness, which is predicted to rise to 12 million cases by 2030. Through this website, we hope to educate people with Alzheimer's and their loved ones about the research, treatment and support available here.

Contact Us

214-645-8800: Clinical appointments in neurology: Cognitive and Memory Disorders Clinic

214-648-9394: Clinic appointments, Dr. Myron Weiner, Geriatric Psychiatry

214-648-9376: Research information: Alzheimer's Disease Center-Memory Research Unit

Latest News:

Alzheimer's Disease Center awarded 5-year, $9 million grant

The National Institute on Aging of the National Institutes of Health has renewed the Alzheimer’s Disease Center (ADC) grant for another five years. The NIH grant award is for $9 million and is the fifth consecutive grant renewal for the ADC dating back to 1988. “We look forward to a highly productive and exciting five years ahead of renewed funding for our research,” said Roger N. Rosenberg, M.D, Director of the ADC.


Early-Stage Efforts to Discover Drugs That Preserve Brain Cells
The Friends of the Alzheimer’s Disease Center hosted a public forum on Wednesday, March 23, to hear Steven McKnight, Ph.D., chairman of UT Southwestern Medical Center’s Department of Biochemistry. Dr. McKnight and his colleagues have discovered, in a laboratory setting, a small molecule that can boost learning and memory as well as prevent new brain cells from dying. They are working to “polish” this early-stage drug lead so that it might help patients suffering from various neurodegenerative diseases, such as Alzheimer’s disease. Andrew Pieper, M.D., Ph.D., one of Dr. McKnight’s co-investigators, partners with him in the presentation.